(2019). ¿Is seropositivity in patients with rheumatoid arthritis treated with adalimumab a factor to develop anti-adalimumab antibodies?
Chicago Style (17th ed.) Citation¿Is Seropositivity in Patients with Rheumatoid Arthritis Treated with Adalimumab a Factor to Develop Anti-adalimumab Antibodies? 2019.
MLA (8th ed.) Citation¿Is Seropositivity in Patients with Rheumatoid Arthritis Treated with Adalimumab a Factor to Develop Anti-adalimumab Antibodies? 2019.
Warning: These citations may not always be 100% accurate.